Impact of Diffuse Myocardial Fibrosis on the Ventricular Function in Regurgitant Left-Sided Valve Heart Diseases ( The DIFFUsE Study)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 316 participants.

Also called NCT02747485

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 316 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02747485
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02747485. Allocation not applicable; no masking; primary purpose prevention. Start 2016-05 (actual); primary completion 2026-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Diffuse Myocardial Fibrosis on the Ventricular Function in Regurgitant Left-Sided Valve Heart Diseases ( The DIFFUsE Study)
Acronym
DIFFUsE
Condition
Valve Heart Diseases
Intervention (Device)
Cardiac MRI
Intervention (Biological)
blood samples
Intervention (Procedure)
myocardial biopsy
Intervention (Genetic)
blood samples
Lead sponsor
Assistance Publique Hopitaux De Marseille (class: other)

Record details

Record id
cardio:ct-nct02747485
Content hash
05667286a57ccec271b0605f493195068d75c6ab9cf5613d6e5ee7bf97103af6